Ll, JR et al. (2012). RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy. Mol Ther 20: 1417423.www.moleculartherapy.org/mtnahrGFP Causes Dose-dependent Muscle Toxicity Wallace et al.4. five. six. 7. eight. 9. ten. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. Wallace, LM, Garwick, SE and Harper, SQ (2010). RNAi therapy for dominant muscular dystrophies and also other myopathies. In: Duan, D (ed.). Muscle Gene Therapy. Springer: New York. pp. 9915. Boudreau, RL, Garwick-Coppens, SE, Liu, J, Wallace, LM and Harper, SQ (2011). Speedy cloning and validation of microRNA shuttle vectors: a practical guide. In: Harper, SQ (ed.). RNA Interference Strategies. Humana Press: New York. pp. 197. Harper, SQ, Staber, PD, He, X, Eliason, SL, Martins, IH, Mao, Q et al. (2005). RNA interference improves motor and neuropathological abnormalities inside a Huntington’s illness mouse model. Proc Natl Acad Sci USA 102: 5820825. Chalfie, M, Tu, Y, Euskirchen, G, Ward, WW and Prasher, DC (1994). Green fluorescent protein as a marker for gene expression. Science 263: 80205. Heim, R, Cubitt, AB and Tsien, RY (1995). Enhanced green fluorescence. Nature 373: 66364. Shimomura, O, Johnson, FH and Saiga, Y (1962). Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J Cell Comp Physiol 59: 22339. Chalfie, M (2009). GFP: Lighting up life. Proc Natl Acad Sci USA 106: 100730080. Tsien, RY (2010). Nobel lecture: constructing and exploiting the fluorescent protein paintbox. Integr Biol (Camb) two: 773. Shimomura, O (2009). Discovery of green fluorescent protein (GFP) (Nobel Lecture).DPN Autophagy Angew Chem Int Ed Engl 48: 5590602. Felts, K, Rogers, B, Chen, K, Ji, H, Sorge, J and Vaillancourt, P (2000). Recombinant Renilla reniformis GFP displays low toxicity. Strateg newsl (Strategene) 13: 857. Ward, WW and Cormier, MJ (1979). An power transfer protein in coelenterate bioluminescence. Characterization of the Renilla green-fluorescent protein. J Biol Chem 254: 78188. McBride, JL, Boudreau, RL, Harper, SQ, Staber, PD, Monteys, AM, Martins, I et al.Mupadolimab In stock (2008).PMID:24293312 Artificial miRNAs mitigate shRNA-mediated toxicity within the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 105: 5868873. Wallace, LM, Garwick, SE, Mei, W, Belayew, A, Coppee, F, Ladner, KJ et al. (2011). DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol 69: 54052. Xia, H, Mao, Q, Eliason, SL, Harper, SQ, Martins, IH, Orr, HT et al. (2004). RNAi suppresses polyglutamine-induced neurodegeneration inside a model of spinocerebellar ataxia. Nat Med ten: 81620. Zeng, X, Chen, J, Sanchez, JF, Coggiano, M, Dillon-Carter, O, Petersen, J et al. (2003). Steady expression of hrGFP by mouse embryonic stem cells: promoter activity within the undifferentiated state and for the duration of dopaminergic neural differentiation. Stem Cells 21: 64753. Vanderbyl, SL, Sullenbarger, B, White, N, Perez, CF, MacDonald, GN, Stodola, T et al. (2005). Transgene expression after steady transfer of a mammalian artificial chromosome into human hematopoietic cells. Exp Hematol 33: 1470476. Hadaczek, P, Forsayeth, J, Mirek, H, Munson, K, Bringas, J, Pivirotto, P et al. (2009). Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. Hum Gene Ther 20: 22537. 21. Glavaski-Joksimovic, A, Virag, T, Mangatu, TA, McGrogan, M, Wang, XS and B.
